https://www.selleckchem.com/products/U0126.html
Treatment with tablet levothyroxine (L-T4) was started and subsequently changed to L-T4 oral solution (Tirosint®-SOL) to overcome treatment administration difficulties encountered with the tablet form. This resulted in improved TSH control due to more accurate and consistent dosing compared with the tablet formulation. This is the first report of the use of L-T4 oral solution in an infant with T21 and biotinidase deficiency. Gestational trophoblastic disease (GTD) which includes hydatidiform mole, invasive mole, placental site trophoblast
Like
Comment
Share
